Kazia Therapeutics (KZIA) Current Leases (2017 - 2018)
Kazia Therapeutics' (KZIA) quarterly Current Leases came in at $63591.1 in Q2 2018, up 746.52% YoY from $7512.1 in Q2 2017, and up 746.52% on a QoQ basis from $7512.1 in Q2 2017.
Kazia Therapeutics (KZIA) Current Leases (2017 - 2018) Analysis & Trends
Kazia Therapeutics (KZIA) has 2 years of Current Leases data on file, last reported at $63591.1 in Q2 2018.
- Quarterly Current Leases rose 746.52% year-over-year to $63591.1 in Q2 2018, while the trailing twelve-month figure through Jun 2018 was $63591.1 (up 746.52% YoY) and the FY2018 annual result came in at $63591.1, up 743.31% from the prior year.
- Current Leases rose to $63591.1 in Q2 2018, from $7512.1 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $63591.1 in Q2 2018 to a low of $7512.1 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 63,591.10 |
| Jun 30, 2017 | 7,512.10 |